CBI books pharma firm directors, officials of Dubai, Patial-based companies in Rs621 cr bank fraud
It is alleged that the accused defrauded the Punjab and Sindh Bank and four other banks of the consortium to the tune of Rs621 crore by diversion and siphoning off the loan
New Delhi: The CBI has registered a case against Surya Pharmaceuticals Ltd, its directors and officials of three companies based in Dubai and Patiala for allegedly cheating a consortium of five banks to the tune of Rs621 crore, officials said on Tuesday.
A case has been registered on charges of criminal conspiracy, cheating, forgery under the provisions of the Prevention of Corruption Act against Surya Pharmaceutical, its promoters and directors Rajeev Goel and Alka Goel. Pramod Aggarwal, director of Dubai-based Kobian Pvt. Ltd and proprietor of Nimbus FZE, and Suhail Goel, director of Patiala-based Emsons Organic Ltd. have also been booked.
“Searches were conducted today at seven places—two each in Delhi, Patiala and Chandigarh and one in Panchkula—at the offices and residences of the accused which led to the recovery of certain documents,” the CBI spokesperson said here.
It is alleged that the accused defrauded the Punjab and Sindh Bank and four other banks of the consortium to the tune of about Rs621 crore by diversion and siphoning off the loan through its sister concerns and not utilizing the credit for the purpose it was sanctioned i.e., manufacturing of pharmaceuticals, the spokesperson said.
Editor's Picks »
- Market optimism before 2019 general election: History may not repeat itself
- UltraTech Cement: No respite from cost pressures
- Mindtree sees strong revenues but client concentration remains high
- Bandhan Bank’s share defies gravity as growth story is intact
- Fund managers slashing allocations to equities in emerging markets, shows BAML survey